Glutathione.
Glutathione (GSH) is a tripeptide of glutamate, cysteine, and glycine that serves as the body's principal intracellular antioxidant and a key cofactor in detoxification.
Glutathione (GSH) is a tripeptide of glutamate, cysteine, and glycine that serves as the body's principal intracellular antioxidant and a key cofactor in detoxification. Glutathione is research / preclinical, and PepCue grades its published evidence D tier (45/100). Also known as GSH · reduced glutathione. This is a research reference, not medical or dosing advice.
What it is
Glutathione (GSH) is a tripeptide of glutamate, cysteine, and glycine that serves as the body's principal intracellular antioxidant and a key cofactor in detoxification. It is produced naturally in every cell and is also sold in oral, inhaled, topical, and injectable (IV/IM) forms. In the antioxidant and longevity space it is promoted for oxidative-stress reduction and, controversially, for skin lightening. Injectable glutathione is not a standardized FDA-approved finished drug in the US and is typically prepared by compounding pharmacies.
How it works
Glutathione neutralizes reactive oxygen species and free radicals directly and as the substrate for glutathione peroxidase enzymes, and it helps regenerate other antioxidants such as vitamins C and E. It also conjugates toxins and drugs during phase II detoxification, making them water-soluble for excretion. Its proposed skin-lightening action is attributed to inhibition of tyrosinase and a shift of melanin synthesis from darker eumelanin toward lighter pheomelanin. Systemic bioavailability, particularly by mouth, is a major limiting factor because glutathione is broken down in the gut.
Mechanism pathways
Handling reactive oxygen species, detoxification conjugation, and cellular redox state.
Cells continuously generate reactive oxygen species as a by-product of aerobic metabolism, and they maintain an elaborate system to keep those species in check. Glutathione is the centre of that system: a tripeptide of glutamate, cysteine, and glycine, present in millimolar concentrations inside cells, and the largest pool of non-protein thiol in the body. Its reactive cysteine sulfhydryl group is what does the work. Glutathione operates in several ways at once. It neutralises radicals directly, and it serves as the substrate for glutathione peroxidase enzymes that reduce hydrogen peroxide and lipid peroxides to harmless products, becoming oxidised to glutathione disulfide in the process and then being regenerated by glutathione reductase using NADPH. The ratio between reduced and oxidised forms is one of the standard measures of a cell's redox state. Glutathione also regenerates other antioxidants including vitamins C and E, so its depletion degrades the whole antioxidant network rather than just one component. Separately, glutathione S-transferases conjugate it to toxins, drugs, and electrophilic metabolites during phase II detoxification, making them water-soluble for excretion, which is why hepatic glutathione depletion is the central event in certain overdose toxicities. A proposed cosmetic application rests on different chemistry: inhibition of tyrosinase, the rate-limiting enzyme in melanin synthesis, and a shift of pigment production from darker eumelanin toward lighter pheomelanin. A second compound is included here because it addresses oxidative damage at its source rather than downstream. By stabilising the inner mitochondrial membrane and the organisation of the electron transport chain, it is proposed to reduce the leakage of electrons that generates reactive oxygen species in the first place, which is conceptually upstream of scavenging them. The honest complication with glutathione is delivery. Oral glutathione is largely broken down into its constituent amino acids in the gut, and the extent to which any intact molecule reaches cells is a long-standing point of contention. Raising intracellular glutathione by supplying cysteine precursors is a better-established route than supplying the tripeptide itself. Intravenous and injected use for skin lightening has been the subject of regulatory safety warnings in several countries, is not an approved indication, and has been associated with serious adverse events. The underlying biochemistry is textbook; the interventions built on it are not.
The evidence
Glutathione's antioxidant and detoxification roles are firmly established biochemistry, and tissue or whole-blood glutathione is routinely measured as a marker of redox status in clinical research. Evidence for cosmetic skin-lightening is much weaker: some small randomized and controlled trials of oral or topical glutathione report modest, often transient reductions in melanin index, but reviews conclude the data are limited, short-term, and insufficient to prove durable benefit. A 2016 Indian Journal of Dermatology, Venereology and Leprology review and a 2025 International Journal of Dermatology systematic review both emphasize that high-quality evidence, especially for intravenous use, is lacking. The individual trials that do exist share a recognizable profile: single-center or small multicenter designs run in Southeast and South Asia, healthy volunteers rather than patients with a defined pigmentary disorder, follow-up measured in weeks to a few months, and melanin index by reflectance spectrophotometry as the primary endpoint rather than any patient-relevant outcome. A double-blind randomized trial of combined topical and oral glutathione published in the International Journal of Dermatology in 2021, and an Indonesian multicenter randomized controlled trial of oral glutathione given together with ascorbic acid, alpha-lipoic acid and zinc aspartate, illustrate both the design and its ambiguity, because combination formulations make it impossible to attribute any observed change to glutathione alone. A 2019 systematic review in the Journal of Cosmetic Dermatology and a 2017 open-label study of oral glutathione in its reduced and oxidized forms reached similarly cautious positions, noting small effect sizes and rapid loss of effect after treatment stops. There is essentially no rigorous trial support for intravenous glutathione as a safe or effective skin-whitening treatment. The intravenous route, which is the most heavily marketed and the most expensive, rests on clinic case series and promotional material rather than controlled comparison, so it is the weakest-supported route despite its commercial prominence. Broader anti-aging or longevity claims in humans likewise remain largely unproven: no registration-quality trial has tested a cosmetic or geroprotective indication, and studies that succeed in raising circulating glutathione have not shown durable effects on aging outcomes. Whether oral dosing meaningfully raises intracellular glutathione at all remains contested, since the tripeptide is extensively hydrolyzed in the gut.
The evidence, in brief
The body's principal intracellular antioxidant, and a tripeptide whose biochemistry is not in doubt. The cosmetic skin-lightening claims are the weak part: reviews of oral and topical use describe modest, short-lived melanin-index changes in small trials, and rigorous support for the intravenous route is absent. IV cosmetic use has been linked to serious reactions and contamination, and the FDA and other regulators have warned against injectable skin-whitening products.
- Glutathione as a skin whitening agent: facts, myths, evidence and controversiesIndian J Dermatol Venereol Leprol, 2016 (PMID 27088927)
- Sarkar R et al.: Glutathione as a skin-lightening agent and in melasma: a systematic reviewInt J Dermatol, 2025 (PMID 39444151)
- DailyMed label search: glutathioneFDA / DailyMed
Evidence maturity
An evidence-only reading: approval status, human vs preclinical data, mechanism and safety. Popularity never raises it. Research file #025
Some human signal atop preclinical work; gaps remain.
Some early human evidence exists but isn't definitive.
Claim receipts
Popular claims about Glutathione, checked against the state of the evidence. The verdict describes evidence maturity, never an invented study result.
Multiple national regulators have warned against injectable skin-whitening products, and reported harms include serious hypersensitivity reactions and contamination incidents.
Its antioxidant and phase II detoxification roles are established biochemistry; the leap to a therapeutic detox benefit is not.
The tripeptide is extensively broken down in the gut, and whether oral use meaningfully raises intracellular levels remains contested.
Small short trials report modest and often transient reductions in melanin index, frequently using combination formulas that make attribution impossible.
Dosing is unstandardized, injectable preparations vary in concentration and purity, and inhaled forms have been reported to provoke bronchoconstriction in some people.
Safety profile
Oral and topical glutathione are generally well tolerated in studies, where reported complaints are mild and mostly gastrointestinal or local, though the trials are too small and too short to detect uncommon harms. Intravenous glutathione for cosmetic use carries documented safety concerns, including reports of serious reactions such as anaphylaxis, Stevens-Johnson syndrome and toxic epidermal necrolysis, and effects on the liver, kidney and thyroid, plus contamination risk (an FDA-cited adverse-event cluster was linked to endotoxin-contaminated compounded product). That cluster is instructive: the hazard came not from the molecule but from the manufacturing chain, which is the recurring pattern for any injectable prepared outside a licensed sterile-fill facility. Dosing is unstandardized, which further compounds the risk, and products marketed for infusion vary in concentration, excipients, preservative content and label accuracy. Because cosmetic infusions are typically given in non-clinical settings, the monitoring a genuine trial would require is usually absent: baseline and follow-up liver and kidney panels, thyroid function, observation for immediate hypersensitivity, sterile technique with documented lot traceability, and a defined adverse-event reporting route. Regulators in several countries have issued warnings precisely because those elements are missing. People with asthma should note that inhaled or nebulized glutathione has been reported to provoke bronchoconstriction in some individuals. This is educational information only and not medical or dosing advice.
Compound notes
- Glutathione (GSH) is a tripeptide of glutamate, cysteine, and glycine: the body's principal intracellular antioxidant and a key cofactor in phase II detoxification.
- It neutralizes reactive oxygen species directly and as the substrate for glutathione peroxidase enzymes, helps regenerate vitamins C and E, and conjugates toxins for excretion.
- Its proposed skin-lightening action is attributed to tyrosinase inhibition and a shift of melanin synthesis from darker eumelanin toward lighter pheomelanin.
- Oral bioavailability is poor because glutathione is broken down in the gut; injectable forms in the US are typically compounded rather than FDA-approved finished drugs.
Oral and topical use are generally well tolerated but show only limited, short-term effects on melanin index. The intravenous cosmetic route has the weakest evidence and the most serious documented harms.
- Not FDA-approved for skin lightening or any cosmetic indication; the FDA and other regulators, including the Philippine FDA and the Saudi SFDA, have warned against injectable skin-whitening products.
- IV cosmetic use has been linked to anaphylaxis, Stevens-Johnson syndrome and toxic epidermal necrolysis, effects on liver, kidney and thyroid, and contamination risk (an FDA-cited adverse-event cluster involved endotoxin-contaminated compounded product).
- Antioxidant and detoxification biochemistry is firmly established, but broader anti-aging and longevity claims in humans remain largely unproven.
Regulatory status
Glutathione is a recognized drug substance that appears in some approved and compounded contexts, but injectable glutathione is not FDA-approved for skin lightening or any cosmetic indication. The US FDA and multiple national regulators (including the Philippine FDA and the Saudi SFDA) have warned against injectable skin-whitening products containing glutathione, and the FDA has cautioned compounding pharmacies after adverse-event reports. Oral and topical glutathione are marketed largely as supplements or cosmetics rather than approved drugs.
Sold research-use-only; human evidence is limited or preclinical.
By the numbers
- 01Tripeptide (glutamate-cysteine-glycine); the body's main intracellular antioxidant
- 02Central to free-radical defense and phase II detoxification
- 03Oral bioavailability is low; injectable forms are typically compounded
- 04Not FDA-approved for skin lightening; FDA and other regulators warn against IV whitening
- 05Skin-lightening evidence is limited, short-term, and weakest for the IV route
- 06IV use has been linked to serious reactions and contamination risk
Glutathione: research formats
Choose the format you are researching to see route-specific notes.
The most common consumer format. Oral bioavailability of intact glutathione is low.
Glutathione is a tripeptide of glutamate, cysteine, and glycine that the body makes in every cell. It is sold in oral, inhaled, topical, and injectable forms, and the oral and topical products are marketed largely as supplements or cosmetics rather than approved drugs. Oral bioavailability of intact glutathione is low, which is why liposomal and precursor-based products exist.
Oral and topical glutathione are generally well tolerated in studies. The skin-lightening evidence for these routes is limited, short-term, and reports modest and often transient changes in melanin index.
Sources
Every factual claim above resolves to a real, published source.
- Glutathione as a skin whitening agent: Facts, myths, evidence and controversiesIndian J Dermatol Venereol Leprol. 2016 (PMID 27088927)
- Glutathione as a skin-lightening agent and in melasma: a systematic reviewSarkar R, et al. Int J Dermatol. 2025 (PMID 39444151)
- DailyMed label search: glutathioneFDA/NLM DailyMed structured product labels
- Glutathione and its antiaging and antimelanogenic effectsWeschawalit S, et al. Clin Cosmet Investig Dermatol. 2017 (PMID 28490897)
- The clinical effect of glutathione on skin color and other related skin conditions: A systematic reviewDilokthornsakul W, et al. J Cosmet Dermatol. 2019 (PMID 30895708)
- Combination of topical and oral glutathione as a skin-whitening agent: a double-blind randomized controlled clinical trialWahab S, et al. Int J Dermatol. 2021 (PMID 33871071)
- PubMed search: intravenous glutathione skin lightening safetyLive PubMed query illustrating the thin controlled-trial base for the injectable route
Cite this page
PepCue. “Glutathione: the evidence.” PepCue, reviewed June 1, 2026. https://www.pepcue.app/p/glutathione.
Log your doses, run the vial math, and keep a provider-ready record in PepCue.